Related Experiment Video
Updated: Sep 18, 2025

Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks
Published on: May 26, 2023
Structural Impact of Anthracene-Appended Mn-MOF on Human Serum Albumin and Its Cellular Implications
Shanmugavel Chinnathambi1, Mahima Kumar1,2, Basudeb Dutta3
1Institute for Integrated Cell-Material Sciences, Institute for Advanced Study, Kyoto University, Kyoto 606-8501, Japan.
Abstract:
Metal-organic frameworks (MOFs) are gaining attention as multifunctional nanomaterials for biomedical applications due to their porosity, tunable structure, and potential for molecular-level imaging. In this study, we synthesized green-emitting, water-dispersible manganese-based MOF (Mn-MOF) nanoparticles for live-cell imaging and investigated their interactions with human serum albumin (HSA). Spectroscopic analyses revealed high-affinity binding, with fluorescence quenching constants in the range of 1013. A red shift in emission and circular dichroism data confirmed that HSA retained its native conformation, underscoring the structural compatibility of Mn-MOFs. Biocompatibility was assessed using HeLa, A549, and chondrocyte cell lines. Cytotoxicity assays showed high cell viability at moderate concentrations and early time points. Nanoparticle size (∼18 nm by DLS; <10 nm by TEM) likely facilitated cellular uptake while minimizing toxicity. Confocal microscopy and flow cytometry revealed efficient internalization via multiple endocytic pathways, with perinuclear localization and no significant morphological changes. However, higher concentrations decreased cell adhesion and viability, indicating a dose-dependent toxicity threshold. These results demonstrate that Mn-MOF nanoparticles maintain protein integrity and exhibit low cytotoxicity, supporting their potential as safe, effective platforms for live-cell imaging and targeted delivery in nanomedicine.
Related Concept Videos
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...

